First immunotherapy regimen for breast cancer gets FDA approval

The US Food and Drug Administration has granted its first approval
to an immunotherapy regimen for breast cancer, the agency announced
Friday. Read more here >>>

thumbnail courtesy of cnn.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here